Role of Neurokinin B and Dynorphin A in pituitary gonadotroph and somatolactotroph cell lines.
The role of Neurokinin B (NKB) and Dynorphin A (Dyn) in the regulation of the hypothalamic pituitary axis is an important area of recent investigation.  These peptides are critical for the rhythmic release of GnRH, which subsequently stimulates the secretion of the gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH).  The present study utilized the gonadotroph cell line LβT2 and the somatolactotroph GH3 cell line to examine the possible role of these peptides in pituitary hormone secretion.  The NKB receptor (NK3R) and the Dyn receptor (the κ-opiate receptor (KOR)) were both detected in LβT2 cells and GH3 cells.  NKB, by itself, failed to increase gonadotropin LHβ and FSHβ promoter activities and did not modulate the effects of GnRH on gonadotropin promoter activity.  In GH3 cells, NKB significantly increased TRH-induced PRL promoter activity although NKB alone did not have an effect on basal PRL promoter activity.  Dyn had no effect on gonadotropin promoters alone or in combination with GnRH stimulation.  PRL promoters stimulated by TRH were not significantly changed by Dyn.  TRH-induced PRL promoter activity was further increased in the presence of higher concentrations of NKB, whereas Dyn did not have a significant effect on the PRL promoter even at a high concentration.  In addition, TRH-induced ERK (Extracelluar signal-regulated kinase) activation was enhanced in the presence of NKB.  Our current study demonstrated that NKB had a stimulatory effect on PRL expression in a PRL-producing cell, but had no effect on gonadotropin secretion from a gonadotroph cell line.
Department of Obstetrics and Gynecology, Shimane University School of Medicine, Izumo 693-8501, Japan.
Tselmeg
T
Mijiddorj
Haruhiko
H
Kanasaki
Indri N
IN
Purwana
Aki
A
Oride
Unurjargar
U
Sukhbaatar
Kohji
K
Miyazaki
D000818:Animals; D002460:Cell Line; D004399:Dynorphins / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D052681:Gonadotrophs / Q000187:drug effects / Q000378:metabolism*; D006062:Gonadotropins / Q000235:genetics / Q000378:metabolism; D052682:Lactotrophs / Q000187:drug effects / Q000378:metabolism*; D015287:Neurokinin B / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D010902:Pituitary Gland / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D011388:Prolactin / Q000235:genetics / Q000378:metabolism; D011401:Promoter Regions, Genetic / Q000187:drug effects; D051381:Rats; D011957:Receptors, Opioid / Q000235:genetics / Q000378:metabolism; D018039:Receptors, Tachykinin / Q000235:genetics / Q000378:metabolism; D052683:Somatotrophs / Q000187:drug effects / Q000378:metabolism*; D014162:Transfection; D000094942:Nociceptin Receptor
D004399:Dynorphins; D006062:Gonadotropins; D015287:Neurokinin B; D011388:Prolactin; D011957:Receptors, Opioid; D018039:Receptors, Tachykinin; D000094942:Nociceptin Receptor; C102505:neurokinin receptor 4; C000722285:Oprl1 protein, rat